Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents.

Identifieur interne : 002323 ( PubMed/Checkpoint ); précédent : 002322; suivant : 002324

A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents.

Auteurs : Greg Smith [Australie] ; Ina Smith ; Bruce Harrower ; David Warrilow ; Cheryl Bletchly

Source :

RBID : pubmed:16677717

Descripteurs français

English descriptors

Abstract

Medical and veterinary diagnostic and public health laboratories world-wide are increasingly being called upon to introduce molecular diagnostic tests for both endemic and exotic diseases. This demand has accelerated following increasing terrorism fears. Ironically these same concerns have lead to tightening of both import and export controls preventing many laboratories, particularly those outside of the United States, from gaining access to positive control material. This in turn has prevented many laboratories from introducing much needed molecular diagnostic tests. We describe here a generic approach for preparing synthetic DNA or RNA control material for use in either TaqMan or conventional PCR assays. The production of synthetic controls using this approach does not require cloning or special equipment or facilities beyond that found in any laboratory performing molecular diagnostics. The approach significantly reduces the possibility of contamination or erroneously reporting false-positive reactions due to contamination from positive control material. Synthetic controls produced using this approach have been employed in all molecular diagnostic tests performed in our laboratory and are used irrespective of whether we possess the organism or not.

DOI: 10.1016/j.jviromet.2006.03.007
PubMed: 16677717


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:16677717

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents.</title>
<author>
<name sortKey="Smith, Greg" sort="Smith, Greg" uniqKey="Smith G" first="Greg" last="Smith">Greg Smith</name>
<affiliation wicri:level="1">
<nlm:affiliation>Public Health Virology, Centre for Public Health Sciences, Queensland Health Scientific Services, 39 Kessels Road, Coopers Plains, Brisbane, Qld 4108, Australia. greg_smith@health.qld.gov.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Public Health Virology, Centre for Public Health Sciences, Queensland Health Scientific Services, 39 Kessels Road, Coopers Plains, Brisbane, Qld 4108</wicri:regionArea>
<wicri:noRegion>Qld 4108</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Smith, Ina" sort="Smith, Ina" uniqKey="Smith I" first="Ina" last="Smith">Ina Smith</name>
</author>
<author>
<name sortKey="Harrower, Bruce" sort="Harrower, Bruce" uniqKey="Harrower B" first="Bruce" last="Harrower">Bruce Harrower</name>
</author>
<author>
<name sortKey="Warrilow, David" sort="Warrilow, David" uniqKey="Warrilow D" first="David" last="Warrilow">David Warrilow</name>
</author>
<author>
<name sortKey="Bletchly, Cheryl" sort="Bletchly, Cheryl" uniqKey="Bletchly C" first="Cheryl" last="Bletchly">Cheryl Bletchly</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16677717</idno>
<idno type="pmid">16677717</idno>
<idno type="doi">10.1016/j.jviromet.2006.03.007</idno>
<idno type="wicri:Area/PubMed/Corpus">002247</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002247</idno>
<idno type="wicri:Area/PubMed/Curation">002247</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002247</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002323</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002323</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents.</title>
<author>
<name sortKey="Smith, Greg" sort="Smith, Greg" uniqKey="Smith G" first="Greg" last="Smith">Greg Smith</name>
<affiliation wicri:level="1">
<nlm:affiliation>Public Health Virology, Centre for Public Health Sciences, Queensland Health Scientific Services, 39 Kessels Road, Coopers Plains, Brisbane, Qld 4108, Australia. greg_smith@health.qld.gov.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Public Health Virology, Centre for Public Health Sciences, Queensland Health Scientific Services, 39 Kessels Road, Coopers Plains, Brisbane, Qld 4108</wicri:regionArea>
<wicri:noRegion>Qld 4108</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Smith, Ina" sort="Smith, Ina" uniqKey="Smith I" first="Ina" last="Smith">Ina Smith</name>
</author>
<author>
<name sortKey="Harrower, Bruce" sort="Harrower, Bruce" uniqKey="Harrower B" first="Bruce" last="Harrower">Bruce Harrower</name>
</author>
<author>
<name sortKey="Warrilow, David" sort="Warrilow, David" uniqKey="Warrilow D" first="David" last="Warrilow">David Warrilow</name>
</author>
<author>
<name sortKey="Bletchly, Cheryl" sort="Bletchly, Cheryl" uniqKey="Bletchly C" first="Cheryl" last="Bletchly">Cheryl Bletchly</name>
</author>
</analytic>
<series>
<title level="j">Journal of virological methods</title>
<idno type="ISSN">0166-0934</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Humans</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (methods)</term>
<term>SARS Virus (isolation & purification)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Humains</term>
<term>RT-PCR ()</term>
<term>Virus du SRAS (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>RT-PCR</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Medical and veterinary diagnostic and public health laboratories world-wide are increasingly being called upon to introduce molecular diagnostic tests for both endemic and exotic diseases. This demand has accelerated following increasing terrorism fears. Ironically these same concerns have lead to tightening of both import and export controls preventing many laboratories, particularly those outside of the United States, from gaining access to positive control material. This in turn has prevented many laboratories from introducing much needed molecular diagnostic tests. We describe here a generic approach for preparing synthetic DNA or RNA control material for use in either TaqMan or conventional PCR assays. The production of synthetic controls using this approach does not require cloning or special equipment or facilities beyond that found in any laboratory performing molecular diagnostics. The approach significantly reduces the possibility of contamination or erroneously reporting false-positive reactions due to contamination from positive control material. Synthetic controls produced using this approach have been employed in all molecular diagnostic tests performed in our laboratory and are used irrespective of whether we possess the organism or not.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">16677717</PMID>
<DateCompleted>
<Year>2006</Year>
<Month>08</Month>
<Day>31</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0166-0934</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>135</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2006</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virological methods</Title>
<ISOAbbreviation>J. Virol. Methods</ISOAbbreviation>
</Journal>
<ArticleTitle>A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents.</ArticleTitle>
<Pagination>
<MedlinePgn>229-34</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Medical and veterinary diagnostic and public health laboratories world-wide are increasingly being called upon to introduce molecular diagnostic tests for both endemic and exotic diseases. This demand has accelerated following increasing terrorism fears. Ironically these same concerns have lead to tightening of both import and export controls preventing many laboratories, particularly those outside of the United States, from gaining access to positive control material. This in turn has prevented many laboratories from introducing much needed molecular diagnostic tests. We describe here a generic approach for preparing synthetic DNA or RNA control material for use in either TaqMan or conventional PCR assays. The production of synthetic controls using this approach does not require cloning or special equipment or facilities beyond that found in any laboratory performing molecular diagnostics. The approach significantly reduces the possibility of contamination or erroneously reporting false-positive reactions due to contamination from positive control material. Synthetic controls produced using this approach have been employed in all molecular diagnostic tests performed in our laboratory and are used irrespective of whether we possess the organism or not.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Greg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Public Health Virology, Centre for Public Health Sciences, Queensland Health Scientific Services, 39 Kessels Road, Coopers Plains, Brisbane, Qld 4108, Australia. greg_smith@health.qld.gov.au</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Ina</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Harrower</LastName>
<ForeName>Bruce</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Warrilow</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bletchly</LastName>
<ForeName>Cheryl</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2006</Year>
<Month>05</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Virol Methods</MedlineTA>
<NlmUniqueID>8005839</NlmUniqueID>
<ISSNLinking>0166-0934</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2005</Year>
<Month>10</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2006</Year>
<Month>03</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2006</Year>
<Month>03</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>5</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2006</Year>
<Month>5</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">16677717</ArticleId>
<ArticleId IdType="pii">S0166-0934(06)00105-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.jviromet.2006.03.007</ArticleId>
<ArticleId IdType="pmc">PMC7112797</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol Methods. 2001 Oct;98(1):33-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11543882</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):289-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15015033</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2002 Feb;8(2):225-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11897082</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2004 Apr;42(4):1471-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15070991</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2002 May;40(5):1575-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11980924</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 1995 Dec;172(6):1641-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7594740</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2002 Apr;66(4):524-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11857532</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Public Health Manag Pract. 2000 Jul;6(4):45-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10977612</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Rev Med Virol. 2005 Sep-Oct;15(5):287-302</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15672450</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMJ. 2005 Sep 17;331(7517):E378-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16166108</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Virol. 2002 Dec;25(3):285-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12423692</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Clin Lab Sci. 2004 Autumn;34(4):389-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15648778</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Bletchly, Cheryl" sort="Bletchly, Cheryl" uniqKey="Bletchly C" first="Cheryl" last="Bletchly">Cheryl Bletchly</name>
<name sortKey="Harrower, Bruce" sort="Harrower, Bruce" uniqKey="Harrower B" first="Bruce" last="Harrower">Bruce Harrower</name>
<name sortKey="Smith, Ina" sort="Smith, Ina" uniqKey="Smith I" first="Ina" last="Smith">Ina Smith</name>
<name sortKey="Warrilow, David" sort="Warrilow, David" uniqKey="Warrilow D" first="David" last="Warrilow">David Warrilow</name>
</noCountry>
<country name="Australie">
<noRegion>
<name sortKey="Smith, Greg" sort="Smith, Greg" uniqKey="Smith G" first="Greg" last="Smith">Greg Smith</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002323 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002323 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:16677717
   |texte=   A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:16677717" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021